Skip to content

Clinical efficacy and mechanism study of pressing needle in the treatment of children with allergic rhinitis

Clinical efficacy and mechanism study of pressing needle in the treatment of children with allergic rhinitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004679
Enrollment
Unknown
Registered
2020-12-12
Start date
2020-12-25
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1) The patients met the diagnostic criteria of allergic rhinitis; 2) Between the ages of 6 and 14 years old, regardless of gender; 3) Sneezing, watery rhinorrhea, itchy nose and nasal congestion occurred in 2 or more cases, lasting for more than 1 hour per day, lasting for more than 4 days a week and / or more than 4 weeks a year on average, and the total course of disease was more than 1 year; 4) The informed consent was signed by the guardian of the subjects. (Only patients who meet the above 4 items can be included in this study).

Exclusion criteria

Exclusion criteria: 1) Any combination with congenital nasal deformity, nasal polyps, chronic rhinosinusitis, asthma, otitis media, bronchitis and other diseases; 2) Patients with heart, lung, liver, kidney, digestive system, hematopoietic system and other serious diseases and mental diseases; 3) Patients who have received or intend to receive specific immunotherapy; 4) A history of receiving antibiotics or acupuncture treatment in the past month, and lasted for 3 days or more; 5) Severe constipation and diarrhea occurred in the past 3 months; 6) Patients who have taken probiotics in the past month; 7) Those who is allergic to stainless steel; 8) Patients who participated in other clinical studies within half a year. (Anyone who meets any of the above should be excluded).

Design outcomes

Primary

MeasureTime frame
Gut microbiota;total nasal symptoms score;Tongue coating microbiota;

Secondary

MeasureTime frame
Pediatrics Rhinoconjunctivitis Quality of Life Questionnaire;Total nasal symptoms visual analogue score;Different nasal symptoms visual analogue score;Quality of life scale for children with allergic rhinitis;

Countries

China

Contacts

Public ContactLing Zhao

Chengdu University of Traditional Chinese Medicine

12249847@qq.com+86 13568801429

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026